SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001894562-23-000013
Filing Date
2023-05-12
Accepted
2023-05-12 16:26:57
Documents
2
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168392320437000.html 3  
1 FORM 3 wf-form3_168392320437000.xml 3 1697
2 EX-24 - JEFFREY MARRAZZO - POA prime-powerofattorneypoase.htm EX-24 4691
  Complete submission text file 0001894562-23-000013.txt   7729
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
Marrazzo Jeffrey D (Reporting) CIK: 0001631262 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41536 | Film No.: 23916222

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)